{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T23:18:54Z","timestamp":1777763934716,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["206632"],"award-info":[{"award-number":["206632"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372875"],"award-info":[{"award-number":["81372875"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402266"],"award-info":[{"award-number":["81402266"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201607040013"],"award-info":[{"award-number":["201607040013"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA151452-01"],"award-info":[{"award-number":["CA151452-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UO1"],"award-info":[{"award-number":["UO1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ygyno.2018.04.557","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T09:57:41Z","timestamp":1524563861000},"page":"143-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Expression and role of autophagy-associated p62 (SQSTM1) in multidrug resistant ovarian cancer"],"prefix":"10.1016","volume":"150","author":[{"given":"Jinglu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassandra","family":"Garbutt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hangzhan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis J.","family":"Hornicek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quancheng","family":"Kan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huirong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenfeng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2018.04.557_bb0005","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0010","first-page":"271","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J. Clin."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2018.04.557_bb0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/ijgc-00009577-200505001-00008","article-title":"Future options for first-line therapy of advanced ovarian cancer","volume":"15","author":"Du Bois","year":"2005","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2018.04.557_bb0020","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1200\/JCO.2010.33.8566","article-title":"Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial","volume":"29","author":"Pignata","year":"2011","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/1758834014544891","article-title":"Neoadjuvant chemotherapy in advanced ovarian cancer: latest results and place in therapy","volume":"6","author":"Sato","year":"2014","journal-title":"Therapeutic advances in medical oncology."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568009033333754","article-title":"Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation","volume":"3","author":"Yusuf","year":"2003","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ygyno.2018.04.557_bb0035","first-page":"266","article-title":"Novel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancer","volume":"1866","author":"Ren","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ygyno.2018.04.557_bb0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szakacs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"35 Suppl","key":"10.1016\/j.ygyno.2018.04.557_bb0045","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.semcancer.2015.03.001","article-title":"Broad targeting of resistance to apoptosis in cancer","author":"Mohammad","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.350","article-title":"Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment","volume":"4","author":"Sui","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.327","article-title":"Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells","volume":"8","author":"Pagotto","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.surg.2014.07.014","article-title":"Autophagy: self-preservation through cannibalism of proteins and organelles","volume":"157","author":"Vlada","year":"2015","journal-title":"Surgery"},{"key":"10.1016\/j.ygyno.2018.04.557_bb0065","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.cell.2014.01.070","article-title":"Atomistic autophagy: the structures of cellular self-digestion","volume":"157","author":"Hurley","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2018.04.557_bb0070","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1101\/gad.1599207","article-title":"Autophagy: process and function","volume":"21","author":"Mizushima","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0075","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.4161\/15548627.2014.981788","article-title":"Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers","volume":"10","author":"Lefort","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.ygyno.2018.04.557_bb0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1182\/blood-2006-10-050260","article-title":"Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance","volume":"110","author":"Carew","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ygyno.2018.04.557_bb0085","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00280-017-3298-5","article-title":"Up-regulation of autophagy is a mechanism of resistance to chemotherapy and can be inhibited by pantoprazole to increase drug sensitivity","volume":"79","author":"Tan","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0090","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1080\/15548627.2015.1017185","article-title":"Elaiophylin, a novel autophagy inhibitor, exerts antitumor activity as a single agent in ovarian cancer cells","volume":"11","author":"Zhao","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.ygyno.2018.04.557_bb0095","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","article-title":"Methods in mammalian autophagy research","volume":"140","author":"Mizushima","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2018.04.557_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)","volume":"12","author":"Klionsky","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.ygyno.2018.04.557_bb0105","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","article-title":"LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing","volume":"19","author":"Kabeya","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0110","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1083\/jcb.200507002","article-title":"p62\/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death","volume":"171","author":"Bjorkoy","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41467-017-00085-7","article-title":"p62\/SQSTM1\/Sequestosome-1 is an N-recognin of the N-end rule pathway which modulates autophagosome biogenesis","volume":"8","author":"Cha-Molstad","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0120","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4161\/auto.7.6.14943","article-title":"p62, Ref(2)P and ubiquitinated proteins are conserved markers of neuronal aging, aggregate formation and progressive autophagic defects","volume":"7","author":"Bartlett","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.ygyno.2018.04.557_bb0125","doi-asserted-by":"crossref","first-page":"9313","DOI":"10.18632\/oncotarget.3220","article-title":"Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer","volume":"6","author":"Gao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2018.04.557_bb0130","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1158\/1535-7163.MCT-09-0115","article-title":"Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines","volume":"8","author":"Duan","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s13402-017-0316-x","article-title":"Inhibition of CDK4 sensitizes multidrug resistant ovarian cancer cells to paclitaxel by increasing apoptosiss","volume":"40","author":"Gao","year":"2017","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0140","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-1-61779-080-5_34","article-title":"Analysis of drug interactions","volume":"731","author":"Bijnsdorp","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0145","article-title":"High LC3\/beclin expression correlates with poor survival in glioma: a definitive role for autophagy as evidenced by in vitro autophagic flux","author":"Cj","year":"2017","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0150","first-page":"28","article-title":"Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas","volume":"e33","author":"Miyamoto","year":"2017","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0155","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1620\/tjem.223.243","article-title":"Overexpression of microtubule-associated protein-1 light chain 3 is associated with melanoma metastasis and vasculogenic mimicry","volume":"223","author":"Han","year":"2011","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0160","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12957-016-0946-x","article-title":"Prognostic relevance of autophagy-related markers LC3, p62\/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status","volume":"14","author":"Schmitz","year":"2016","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0165","doi-asserted-by":"crossref","first-page":"17163","DOI":"10.1074\/jbc.M114.558288","article-title":"Role of autophagy in cisplatin resistance in ovarian cancer cells","volume":"289","author":"Wang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0170","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3892\/mmr.2014.2671","article-title":"Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells","volume":"11","author":"Bao","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0175","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/CMAR.S34859","article-title":"Targeting autophagy in cancer management - strategies and developments","volume":"7","author":"Ozpolat","year":"2015","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0180","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.3892\/ijo.2015.2937","article-title":"Autophagy inhibition enhances sensitivity of endometrial carcinoma cells to paclitaxel","volume":"46","author":"Liu","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0185","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fnins.2017.00078","article-title":"The autophagy machinery: a new player in chemotactic cell migration","volume":"11","author":"Coly","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0190","doi-asserted-by":"crossref","first-page":"12803","DOI":"10.18632\/oncotarget.2516","article-title":"Pilot study of p62 DNA vaccine in dogs with mammary tumors","volume":"5","author":"Gabai","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2018.04.557_bb0195","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/08830185.2014.954699","article-title":"Feasibility analysis of p62 (SQSTM1)-encoding DNA vaccine as a novel cancer immunotherapy","volume":"33","author":"Gabai","year":"2014","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.ygyno.2018.04.557_bb0200","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.18632\/oncotarget.1397","article-title":"Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector","volume":"4","author":"Venanzi","year":"2013","journal-title":"Oncotarget"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818308357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818308357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:57:35Z","timestamp":1777474655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825818308357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0090825818308357"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.04.557","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression and role of autophagy-associated p62 (SQSTM1) in multidrug resistant ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.04.557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}